CareLit · DOI-Nachweis · Klinische Pädiatrie
Immunotherapy for malignant glioma: preclinical models to improve efficacy of the immune attack
DOI 10.1055/s-0031-1292596
Bibliografische Angaben
Nachweis in CareLit
Autor:innenL Vandenberk, T Verschuere, K Vanhoven, C KDks, S De Vleeschouwer, SW Van Gool
ZeitschriftKlinische Pädiatrie
Ausgabe11/2011
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
The prognosis of high grade glioma (HGG) is poor in spite of advanced neurosurgery, radio- and chemotherapy. Evidence appears that active specific immunotherapy with mature dendritic cells loaded with tumor lysate (DCm-HGG-L) might induce long term survival. In our preclinical GL261 model, we are now looking for strategies to improve the efficacy of the immune attack. For this, we are approaching two key molecules o…
Zitieren
Zitierempfehlung
L Vandenberk, T Verschuere, K Vanhoven, C KDks, S De Vleeschouwer, SW Van Gool (2011) Immunotherapy for malignant glioma: preclinical models to improve efficacy of the immune attack. Klinische Pädiatrie (11). https://doi.org/10.1055/s-0031-1292596
Mit CareLit weiterarbeiten